Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 1.1 (8 November 2007 and included in variation EMEA/ H/ C/ 788/ II/ 06) presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.